Clinical Research Details

Clinical Research

An Open-Label Extension Study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease

Study Description

The purpose of this research study is to provide or continue to provide inhaled treprostinil to eligible subjects who participated in the RIN-PH-201 study. The study will also investigate the safety and how well inhaled treprostinil works in subjects with PH associated with ILD or CPFE. This study will look at your ability to exercise after taking the study drug.

Investigators


Principal Investigator
Vandana K. Seeram, M.B.B.S. (M.D.)
Medicine

Sub Investigator
James D. Cury, M.D.
Medicine

Sub Investigator
Lisa M. Jones, M.D.
Medicine

Sub Investigator
Mariam Louis, M.D.
Medicine